FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2443576891> ?p ?o ?g. }

• W2443576891 endingPage "677" @default.
• W2443576891 startingPage "666" @default.
• W2443576891 abstract "Successful treatment of Mycobacterium tuberculosis infection typically requires a complex regimen administered over at least 6 months. Interestingly, many of the antibiotics used to treat M. tuberculosis are prodrugs that require intracellular activation. Here, we describe three small molecules, active against both replicating and non-replicating M. tuberculosis, that require activation by Baeyer-Villiger monooxygenases (BVMOs). Two molecules require BVMO EthA (Rv3854c) for activation and the third molecule requires the BVMO MymA (Rv3083). While EthA is known to activate the antitubercular drug ethionamide, this is the first description of MymA as an activating enzyme of a prodrug. Furthermore, we found that MymA also plays a role in activating ethionamide, with loss of MymA function resulting in ethionamide-resistant M. tuberculosis. These findings suggest overlap in function and specificity of the BVMOs in M. tuberculosis." @default.
• W2443576891 created "2016-06-24" @default.
• W2443576891 creator A5009509285 @default.
• W2443576891 creator A5016364532 @default.
• W2443576891 creator A5018593353 @default.
• W2443576891 creator A5020438405 @default.
• W2443576891 creator A5025994433 @default.
• W2443576891 creator A5029487525 @default.
• W2443576891 creator A5029725845 @default.
• W2443576891 creator A5038739772 @default.
• W2443576891 creator A5042211416 @default.
• W2443576891 creator A5043696594 @default.
• W2443576891 creator A5070261986 @default.
• W2443576891 creator A5070917621 @default.
• W2443576891 creator A5079515502 @default.
• W2443576891 creator A5083680583 @default.
• W2443576891 creator A5091035225 @default.
• W2443576891 date "2016-06-01" @default.
• W2443576891 modified "2023-10-01" @default.
• W2443576891 title "Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis Inhibitors" @default.
• W2443576891 cites W1543200780 @default.
• W2443576891 cites W1762020366 @default.
• W2443576891 cites W1976256007 @default.
• W2443576891 cites W1981198757 @default.
• W2443576891 cites W1986288809 @default.
• W2443576891 cites W1987681862 @default.
• W2443576891 cites W1991874243 @default.
• W2443576891 cites W1993006454 @default.
• W2443576891 cites W1996907187 @default.
• W2443576891 cites W2008952784 @default.
• W2443576891 cites W2015142714 @default.
• W2443576891 cites W2015452345 @default.
• W2443576891 cites W2015771874 @default.
• W2443576891 cites W2019248509 @default.
• W2443576891 cites W2019835759 @default.
• W2443576891 cites W2020767338 @default.
• W2443576891 cites W2035220217 @default.
• W2443576891 cites W2050917919 @default.
• W2443576891 cites W2052554152 @default.
• W2443576891 cites W2058022151 @default.
• W2443576891 cites W2059750112 @default.
• W2443576891 cites W2066958748 @default.
• W2443576891 cites W2071914853 @default.
• W2443576891 cites W2104750364 @default.
• W2443576891 cites W2124075951 @default.
• W2443576891 cites W2135681003 @default.
• W2443576891 cites W2140586560 @default.
• W2443576891 cites W2158658436 @default.
• W2443576891 cites W2160143801 @default.
• W2443576891 cites W2164087631 @default.
• W2443576891 cites W2167605787 @default.
• W2443576891 cites W2264219219 @default.
• W2443576891 cites W2335742497 @default.
• W2443576891 cites W4237342534 @default.
• W2443576891 doi "https://doi.org/10.1016/j.chembiol.2016.05.011" @default.
• W2443576891 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4920728" @default.
• W2443576891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27321573" @default.
• W2443576891 hasPublicationYear "2016" @default.
• W2443576891 type Work @default.
• W2443576891 sameAs 2443576891 @default.
• W2443576891 citedByCount "43" @default.
• W2443576891 countsByYear W24435768912017 @default.
• W2443576891 countsByYear W24435768912018 @default.
• W2443576891 countsByYear W24435768912019 @default.
• W2443576891 countsByYear W24435768912020 @default.
• W2443576891 countsByYear W24435768912021 @default.
• W2443576891 countsByYear W24435768912022 @default.
• W2443576891 countsByYear W24435768912023 @default.
• W2443576891 crossrefType "journal-article" @default.
• W2443576891 hasAuthorship W2443576891A5009509285 @default.
• W2443576891 hasAuthorship W2443576891A5016364532 @default.
• W2443576891 hasAuthorship W2443576891A5018593353 @default.
• W2443576891 hasAuthorship W2443576891A5020438405 @default.
• W2443576891 hasAuthorship W2443576891A5025994433 @default.
• W2443576891 hasAuthorship W2443576891A5029487525 @default.
• W2443576891 hasAuthorship W2443576891A5029725845 @default.
• W2443576891 hasAuthorship W2443576891A5038739772 @default.
• W2443576891 hasAuthorship W2443576891A5042211416 @default.
• W2443576891 hasAuthorship W2443576891A5043696594 @default.
• W2443576891 hasAuthorship W2443576891A5070261986 @default.
• W2443576891 hasAuthorship W2443576891A5070917621 @default.
• W2443576891 hasAuthorship W2443576891A5079515502 @default.
• W2443576891 hasAuthorship W2443576891A5083680583 @default.
• W2443576891 hasAuthorship W2443576891A5091035225 @default.
• W2443576891 hasBestOaLocation W24435768911 @default.
• W2443576891 hasConcept C108215921 @default.
• W2443576891 hasConcept C142724271 @default.
• W2443576891 hasConcept C185592680 @default.
• W2443576891 hasConcept C2776228421 @default.
• W2443576891 hasConcept C2776448121 @default.
• W2443576891 hasConcept C2777204207 @default.
• W2443576891 hasConcept C2777975735 @default.
• W2443576891 hasConcept C2779685592 @default.
• W2443576891 hasConcept C2780374374 @default.
• W2443576891 hasConcept C2781069245 @default.
• W2443576891 hasConcept C501593827 @default.
• W2443576891 hasConcept C71924100 @default.
• W2443576891 hasConcept C86803240 @default.

• next